Skip to main content
Christiane Querfeld, MD, Dermatology, Duarte, CA

ChristianeQuerfeldMDPhD

Dermatology Duarte, CA

Dermatopathology

Professor; Dermatology/Dermatopathology; Director, Cutaneous Lymphoma Program

Dr. Querfeld is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Querfeld's full profile

Already have an account?

  • Office

    1500 Duarte Rd
    Duarte, CA 91010
    Phone+1 626-775-3514
    Fax+1 626-218-5310

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Dermatopathology, 2010 - 2011
  • University of Chicago
    University of ChicagoResidency, Dermatology, 2007 - 2010
  • Good Samaritan Hospital of Maryland
    Good Samaritan Hospital of MarylandInternship, Internal Medicine, 2006 - 2007
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Dermatology, 2002 - 2004
  • University of Heidelberg
    University of HeidelbergPhD, Microbiology/Immunology, 1995
  • Univ Cologne- Fac Med
    Univ Cologne- Fac MedClass of 1994

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2014 - 2025
  • NY State Medical License
    NY State Medical License 2011 - 2016
  • IL State Medical License
    IL State Medical License 2010 - 2014
  • American Board of Dermatology Dermatology
  • American Board of Dermatology Dermatopathology

Awards, Honors, & Recognition

  • Scholar in Clinical Research Leukemia Lymphoma Society, 2018
  • Excellence Award City of Hope, 2017
  • Junior Investigator Research Development Award City of Hope, 2016
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Bnz-1, a Selective _-Chain Cytokine Inhibitor Has Clinical Activity in Patients with Cutaneous T Cell Lymphoma By Selectively Blocking IL-2, IL-15 and IL-9 Signaling: ... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Phase 1 Results of Anti-PD-Ligand 1 (Durvalumab) & Lenalidomide in Patients with Cutaneous T Cell Lymphoma and Correlation with Programmed Death Ligand 1 Expression an... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Intralesional Administration of the CD47 Antagonist TTI-621 (SIRPαFc) Induces Responses in Both Injected and Non-Injected Lesions in Patients with Relapsed/Refractory ... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • City of Hope Doctors and Scientists Present Research on Novel Cancer Therapies at American Society of Hematology (ASH) Annual Conference
    City of Hope Doctors and Scientists Present Research on Novel Cancer Therapies at American Society of Hematology (ASH) Annual ConferenceDecember 10th, 2024
  • A Study Associates the Use of Hydroquinone with the Risk of Skin Cancer -News Forest
    A Study Associates the Use of Hydroquinone with the Risk of Skin Cancer -News ForestAugust 26th, 2022
  • Regional Lymph Nodes Guarded by Immune Cells
    Regional Lymph Nodes Guarded by Immune CellsOctober 4th, 2021
  • Join now to see all

Professional Memberships

Other Languages

  • German